NCT00157248View on ClinicalTrials.gov

Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048

PHASE2TerminatedINTERVENTIONAL
Enrollment

361

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

January 31, 2009

Conditions
Atrial FibrillationStroke
Interventions
DRUG

dabigatran etexilate

dosage used at study start

DRUG

dabigatran etexilate

dosage used at study start

DRUG

dabigatran etexilate

dosage used at study start

DRUG

dabigatran etexilate

dosage used at study start

Trial Locations (50)

Unknown

1160.42.10003 Boehringer Ingelheim Investigational Site, La Mesa

1160.42.10006 Boehringer Ingelheim Investigational Site, Pensacola

1160.42.10004 Boehringer Ingelheim Investigational Site, Port Charlotte

1160.42.10002 Boehringer Ingelheim Investigational Site, St. Petersburg

1160.42.10015 Boehringer Ingelheim Investigational Site, Baltimore

1160.42.10008 Boehringer Ingelheim Investigational Site, Westminster

1160.42.10012 Boehringer Ingelheim Investigational Site, Pittsfield

1160.42.10007 Boehringer Ingelheim Investigational Site, Troy

1160.42.10014 Boehringer Ingelheim Investigational Site, Hawthorne

1160.42.10013 Boehringer Ingelheim Investigational Site, New Hyde Park

1160.42.10009 Boehringer Ingelheim Investigational Site, North Durham

1160.42.10001 Boehringer Ingelheim Investigational Site, Philadelphia

1160.42.45010 Boehringer Ingelheim Investigational Site, Aalborg

1160.42.45005 Boehringer Ingelheim Investigational Site, Aarhus C

1160.42.45007 Boehringer Ingelheim Investigational Site, Brædstrup

1160.42.45003 Boehringer Ingelheim Investigational Site, Elsinore

1160.42.45011 Boehringer Ingelheim Investigational Site, Esbjerg

1160.42.45012 Boehringer Ingelheim Investigational Site, Frederikssund

1160.42.45004 Boehringer Ingelheim Investigational Site, Herlev

1160.42.45009 Boehringer Ingelheim Investigational Site, Holbæk

1160.42.45002 Boehringer Ingelheim Investigational Site, Hvidovre

1160.42.45014 Boehringer Ingelheim Investigational Site, Køge

1160.42.45001 Boehringer Ingelheim Investigational Site, Odense

1160.42.45013 Roskilde Sygehus, Roskilde

1160.42.45006 Boehringer Ingelheim Investigational Site, Svendborg

1160.42.31003 Ziekenhuis Amstelveen, Amstelveen

1160.42.31001 Academisch Medisch Centrum, Amsterdam

1160.42.31013 Onze Lieve Vrouwe Gasthuis, Amsterdam

1160.42.31008 Gelre Ziekenhuis, locatie Juliana, Apeldoorn

1160.42.31006 Wilhelmina Ziekenhuis, Assen

1160.42.31007 Gemini Ziekenhuis, Den Helder

1160.42.31002 Ziekenhuis Gelderse Vallei, Ede

1160.42.31014 Ziekenhuisgroep Twente, Hengelo

1160.42.31012 Vasculair onderzoekscentrum (VOC), Hoorn

1160.42.31009 Havenziekenhuis, Rotterdam

1160.42.31004 Maasland Ziekenhuis, Sittard

1160.42.31005 Tweesteden Ziekenhuis, Tilburg

1160.42.31011 Maxima Medisch Centrum, Veldhoven

1160.42.46013 Boehringer Ingelheim Investigational Site, Eskilstuna

1160.42.46007 Boehringer Ingelheim Investigational Site, Falun

1160.42.46005 Boehringer Ingelheim Investigational Site, Jönköping

1160.42.46010 Boehringer Ingelheim Investigational Site, Kalmar

1160.42.46009 Boehringer Ingelheim Investigational Site, Malmo

1160.42.46008 Boehringer Ingelheim Investigational Site, Norrköping

1160.42.46004 Boehringer Ingelheim Investigational Site, Örebro

1160.42.46002 Boehringer Ingelheim Investigational Site, Stockholm

1160.42.46011 Boehringer Ingelheim Investigational Site, Stockholm

1160.42.46006 Boehringer Ingelheim Investigational Site, Umeaa

1160.42.46001 Boehringer Ingelheim Investigational Site, Uppsala

1160.42.46003 Boehringer Ingelheim Investigational Site, Västerås

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY